Guy S. Goodwin-Gill Professor, University of New South Wales & Kaldor Centre for International Refugee Law, Sydney 23 October 2018...
One of Australia's most highly credentialled and internationally esteemed academics and university leaders, Professor Michael McRobbie AO, is to receive an Honorary Doctorate from Griffith University.
As the Gold Coast grapples with uncertainty over its identity and a blueprint for the future, a symposium organised by...
Wollin J, Fulcher G, McDonald E, Spencer N, Mortlock M, Bourne M, Simmons R. (2010) Psychosocial Factors That Influence Quality...
Henderson S, Kendall E. (2010) Culturally and linguistically diverse peoples’ knowledge of accessibility and utilisation of health services: exploring the...
Strep A (Streptococcus pyogenes) is a major cause of infection-related deaths, leading to over 500,000 fatalities annually. Developing countries, Indigenous populations, and vulnerable groups face the greatest risks. A potential vaccine, developed by Professor Michael Good's team at Griffith University, is undergoing human trials and shows promise in fighting multiple Strep A strains.
Foremost Australian medical researchers, Professor Mark von Itzstein and Professor Michael Good from Griffith’s Institute for Glycomics have been honoured with election to Fellowship in the Australian Academy of Health & Medical Science.
In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for...
Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
